Coronapod: COVID boosters amidst global vacci...

Nature staff discuss an AI tool that can assess the impact of nine billion mutations — plus, how the Bunsen burner’s reputation for sterilization may be based on tradition alone.00:21 Deepmind’s new tool helps scientists find the impact of mutationsNature: DeepMind’s new genome ‘ ...  Show more

In this episode:00:46 How telephone teaching could boost education during school shutdownsNature: Pick up the phone! Phone calls with tutors keep kids learning when schools shut down11:42 Research HighlightsNature: Super-precise optical clocks in four nations tick in harmonyNatur ...  Show more

In a race to catch up with emerging coronavirus variants, wealthy countries are already benefiting from potent vaccines. While the U.S., Britain and European Union have given citizens about 24 million doses so far -- more than half of the shots administered globally -- vast numbe ...  Show more

The divide between the Covid vaccine haves and have-nots has been described as “criminal”, with only 20% of people in low and middle income countries having had one dose, compared with 80% in higher income countries. Countries with high vaccination rates have been called on to gi ...  Show more

The boosters are rolling out. In places likes the U.S., Britain, and Israel, authorities are providing additional Covid-19 vaccines with the goal of bolstering immune systems and shoring up their economies. Though vaccines such as Moderna and Pfizer-BioNTech have proven highly ef ...  Show more

The rise of the Delta variant has prompted a thorny question: Do we need a booster dose of the vaccine for Covid-19? Vaccine makers think so, but regulators are yet to be convinced.

Principles are also at stake: Should richer countries be talking about administering extr ...